QQQ   438.27 (-1.59%)
AAPL   176.55 (+0.86%)
MSFT   421.90 (-1.41%)
META   511.90 (-2.15%)
GOOGL   157.73 (-1.05%)
AMZN   186.13 (-1.54%)
TSLA   171.05 (-2.03%)
NVDA   881.86 (-2.68%)
AMD   163.28 (-4.23%)
NIO   4.11 (-7.85%)
BABA   71.29 (-4.76%)
T   16.31 (-0.67%)
F   12.61 (-3.30%)
MU   122.52 (-3.91%)
GE   154.63 (-1.93%)
CGC   7.80 (-4.29%)
DIS   114.01 (-2.68%)
AMC   2.65 (-5.36%)
PFE   25.86 (-1.82%)
PYPL   64.59 (-1.84%)
XOM   120.37 (-1.17%)
QQQ   438.27 (-1.59%)
AAPL   176.55 (+0.86%)
MSFT   421.90 (-1.41%)
META   511.90 (-2.15%)
GOOGL   157.73 (-1.05%)
AMZN   186.13 (-1.54%)
TSLA   171.05 (-2.03%)
NVDA   881.86 (-2.68%)
AMD   163.28 (-4.23%)
NIO   4.11 (-7.85%)
BABA   71.29 (-4.76%)
T   16.31 (-0.67%)
F   12.61 (-3.30%)
MU   122.52 (-3.91%)
GE   154.63 (-1.93%)
CGC   7.80 (-4.29%)
DIS   114.01 (-2.68%)
AMC   2.65 (-5.36%)
PFE   25.86 (-1.82%)
PYPL   64.59 (-1.84%)
XOM   120.37 (-1.17%)
QQQ   438.27 (-1.59%)
AAPL   176.55 (+0.86%)
MSFT   421.90 (-1.41%)
META   511.90 (-2.15%)
GOOGL   157.73 (-1.05%)
AMZN   186.13 (-1.54%)
TSLA   171.05 (-2.03%)
NVDA   881.86 (-2.68%)
AMD   163.28 (-4.23%)
NIO   4.11 (-7.85%)
BABA   71.29 (-4.76%)
T   16.31 (-0.67%)
F   12.61 (-3.30%)
MU   122.52 (-3.91%)
GE   154.63 (-1.93%)
CGC   7.80 (-4.29%)
DIS   114.01 (-2.68%)
AMC   2.65 (-5.36%)
PFE   25.86 (-1.82%)
PYPL   64.59 (-1.84%)
XOM   120.37 (-1.17%)
QQQ   438.27 (-1.59%)
AAPL   176.55 (+0.86%)
MSFT   421.90 (-1.41%)
META   511.90 (-2.15%)
GOOGL   157.73 (-1.05%)
AMZN   186.13 (-1.54%)
TSLA   171.05 (-2.03%)
NVDA   881.86 (-2.68%)
AMD   163.28 (-4.23%)
NIO   4.11 (-7.85%)
BABA   71.29 (-4.76%)
T   16.31 (-0.67%)
F   12.61 (-3.30%)
MU   122.52 (-3.91%)
GE   154.63 (-1.93%)
CGC   7.80 (-4.29%)
DIS   114.01 (-2.68%)
AMC   2.65 (-5.36%)
PFE   25.86 (-1.82%)
PYPL   64.59 (-1.84%)
XOM   120.37 (-1.17%)

NeoGenomics (NEO) Earnings Date, Estimates & Call Transcripts

$14.08
-0.44 (-3.03%)
(As of 04:29 PM ET)

Earnings Summary

Upcoming
Earnings Date
Apr. 30
Before Market Opens
Confirmed
Actual EPS
(Feb. 20)
-$0.02 Beat By $0.05
Consensus EPS
(Feb. 20)
-$0.07
Skip Charts & View Estimated and Actual Earnings Data

NEO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NEO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

NeoGenomics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242($0.13)($0.08)($0.11) 
Q2 20242($0.11)($0.04)($0.08) 
Q3 20242($0.08)($0.04)($0.06) 
Q4 20243($0.07)($0.01)($0.05) 
FY 20249($0.39)($0.17)($0.29) 
Q1 20252($0.07)($0.04)($0.06) 
Q2 20252($0.06)($0.03)($0.05) 
Q3 20252($0.05)($0.01)($0.03) 
Q4 20251$0.02$0.02$0.02 
FY 20257($0.16)($0.06) ($0.11)

NEO Earnings Date and Information

NeoGenomics last posted its quarterly earnings results on February 20th, 2024. The medical research company reported ($0.02) EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.05. The firm earned $155.55 million during the quarter, compared to analysts' expectations of $152.90 million. NeoGenomics has generated ($0.70) earnings per share over the last year (($0.70) diluted earnings per share). Earnings for NeoGenomics are expected to grow in the coming year, from ($0.20) to ($0.10) per share. NeoGenomics has confirmed that its next quarterly earnings report will be published on Tuesday, April 30th, 2024. NeoGenomics will be holding an earnings conference call on Tuesday, April 30th at 8:30 AM Eastern. Interested parties can register for or listen to the call..

NeoGenomics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/30/2024
Confirmed)
-------  
2/20/2024Q4 2023($0.07)($0.02)+$0.05$0.07$152.90 million$155.55 million
11/6/2023Q3 2023($0.11)($0.06)+$0.05$0.03$142.15 million$151.95 million
8/8/2023Q2 2023($0.15)($0.09)+$0.06$0.01$138.22 million$146.92 million
5/8/2023Q1 2023($0.16)($0.13)+$0.03($0.01)$126.31 million$137.22 million
2/23/2023Q4 2022($0.19)($0.10)+$0.09($0.02)$129.96 million$138.71 million
11/8/2022Q3 2022($0.23)($0.17)+$0.06($0.04)$122.55 million$128.78 million
8/9/2022Q2 2022($0.28)($0.19)+$0.09($0.10)$123.26 million$125.00 million      
4/27/2022Q1 2022($0.28)($0.30)($0.02)($0.20)$116.44 million$117.17 million    
2/23/2022Q4 2021($0.17)($0.14)+$0.03$0.06$125.77 million$125.73 million    
11/4/2021Q3 2021($0.09)($0.08)+$0.01($0.09)$125.09 million$121.30 million    
8/6/2021Q2 2021($0.08)($0.04)+$0.04($0.67)$120.50 million$121.72 million
5/5/2021Q1 2021$0.01($0.04)($0.05)$0.07$112.17 million$115.30 million    

NeoGenomics Earnings - Frequently Asked Questions

When is NeoGenomics's earnings date?

NeoGenomics has confirmed that its next quarterly earnings data will be published on Tuesday, April 30th, 2024. Learn more on NEO's earnings history.

Did NeoGenomics beat their earnings estimates last quarter?

In the previous quarter, NeoGenomics (NASDAQ:NEO) reported ($0.02) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.07) by $0.05. Learn more on analysts' earnings estimate vs. NEO's actual earnings.

How much revenue does NeoGenomics generate each year?

NeoGenomics (NASDAQ:NEO) has a recorded annual revenue of $591.64 million.

How much profit does NeoGenomics generate each year?

NeoGenomics (NASDAQ:NEO) has a recorded net income of -$87.97 million. NEO has generated -$0.70 earnings per share over the last four quarters.

What is NeoGenomics's EPS forecast for next year?

NeoGenomics's earnings are expected to grow from ($0.20) per share to ($0.10) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:NEO) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners